Bin Guo1, Wenjian Zhang2, Shiqing Xu2, Jinning Lou2, Shuxia Wang3, Xiuli Men4. 1. Department of Pathophysiology, North China University of Science and Technology,Tangshan 063000, People's Republic of China. 2. Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, People's Republic of China. 3. Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY 40536, USA. Electronic address: swang7@uky.edu. 4. Department of Pathophysiology, North China University of Science and Technology,Tangshan 063000, People's Republic of China. Electronic address: xiulimen@126.com.
Abstract
AIMS: Glucocorticoids, such as dexamethasone, are widely used anti-inflammatory drugs. Their use is frequently associated with the development of steroid- associated diabetes. Pancreatic β-cell dysfunction has been suggested to be one of the main causes of steroid-associated diabetes. However, the mechanism is not fully understood. Glycogen synthase kinase-3β (GSK-3β) is a multifunctional serine/threonine kinase and plays an important role in energy metabolism, cell growth and apoptosis. Therefore, the contribution of GSK-3β in dexamethasone-induced pancreatic β-cell apoptosis was determined in the present study. MAIN METHODS: The effect of dexamethasone treatment on rat pancreatic β-cell line (INS-1) apoptosis (determined by TUNEL and Flow Cytometry), generation of reactive oxidative stress (ROS), and the phosphorylation status of GSK-3β was determined. The inhibitory effect of GSK-3β inhibitor-lithium chloride (LiCl) on dexamethasone-induced β-cell apoptosis was also evaluated. KEY FINDINGS: Dexamethasone (0.1 μM) treatment induced INS-1 apoptosis, which was associated with increased GSK-3β activation and increased NOX4-derived ROS generation. Pretreatment of INS-1 with LiCl inhibited dexamethasone induced ROS generation and INS-1 apoptosis. SIGNIFICANCE: This study provides a new mechanism of Dex induced pancreatic β cell apoptosis and may serve as a new therapeutic option for treating GC induced diabetes.
AIMS: Glucocorticoids, such as dexamethasone, are widely used anti-inflammatory drugs. Their use is frequently associated with the development of steroid- associated diabetes. Pancreatic β-cell dysfunction has been suggested to be one of the main causes of steroid-associated diabetes. However, the mechanism is not fully understood. Glycogen synthase kinase-3β (GSK-3β) is a multifunctional serine/threonine kinase and plays an important role in energy metabolism, cell growth and apoptosis. Therefore, the contribution of GSK-3β in dexamethasone-induced pancreatic β-cell apoptosis was determined in the present study. MAIN METHODS: The effect of dexamethasone treatment on ratpancreatic β-cell line (INS-1) apoptosis (determined by TUNEL and Flow Cytometry), generation of reactive oxidative stress (ROS), and the phosphorylation status of GSK-3β was determined. The inhibitory effect of GSK-3β inhibitor-lithium chloride (LiCl) on dexamethasone-induced β-cell apoptosis was also evaluated. KEY FINDINGS:Dexamethasone (0.1 μM) treatment induced INS-1 apoptosis, which was associated with increased GSK-3β activation and increased NOX4-derived ROS generation. Pretreatment of INS-1 with LiCl inhibited dexamethasone induced ROS generation and INS-1 apoptosis. SIGNIFICANCE: This study provides a new mechanism of Dex induced pancreatic β cell apoptosis and may serve as a new therapeutic option for treating GC induced diabetes.
Authors: Piyajit Watcharasit; Gautam N Bijur; Jaroslaw W Zmijewski; Ling Song; Anna Zmijewska; Xinbin Chen; Gail V W Johnson; Richard S Jope Journal: Proc Natl Acad Sci U S A Date: 2002-06-04 Impact factor: 11.205
Authors: E B Peixoto; A Papadimitriou; D A T Teixeira; C Montemurro; D A Duarte; K C Silva; P P Joazeiro; J M Lopes de Faria; J B Lopes de Faria Journal: J Nutr Biochem Date: 2015-01-13 Impact factor: 6.048
Authors: Chien-Ting Wu; Peter V Lidsky; Yinghong Xiao; Ivan T Lee; Ran Cheng; Tsuguhisa Nakayama; Sizun Jiang; Janos Demeter; Romina J Bevacqua; Charles A Chang; Robert L Whitener; Anna K Stalder; Bokai Zhu; Han Chen; Yury Goltsev; Alexandar Tzankov; Jayakar V Nayak; Garry P Nolan; Matthias S Matter; Raul Andino; Peter K Jackson Journal: Cell Metab Date: 2021-05-18 Impact factor: 27.287
Authors: Mona F Mahmoud; Asmaa M Elmaghraby; Noura Ali; Islam Mostafa; Assem M El-Shazly; Mohamed A O Abdelfattah; Mansour Sobeh Journal: Biomed Pharmacother Date: 2022-07-27 Impact factor: 7.419